PRESENTATION

Q2 FY2021 — Presentation

Q2 FY2021PDF · 25 pages1.5 MB
© 2021 Lam Research Corp. | 01/27/2021 	1
Lam Research Corporation
December Quarter 2020 Financial Results
January 27, 2021

-- 1 of 25 --

© 2021 Lam Research Corp. | 01/27/2021 	2
This presentation and the accompanying discussion contain “forward-looking statements” under U.S. securities laws. Forward-looking
statements include any statements that are not statements of historical fact. 	Examples of forward-looking statements include, but are
not limited to: (1) anticipated business, balance sheet, cash flow and financial measures and results, including guidance, whether on a
GAAP or non-GAAP basis; (2) economic, market, industry and industry segment expectations; (3) product performance and changes in
market share or customer demands; (4) our ability to successfully execute business, capital allocation, product and growth plans or
strategies, or otherwise deliver value for customers and stockholders; (5) the impact of the COVID-19 pandemic on our operations and
financial results, and our ability to mitigate operational and business impacts caused by it; and (6) the impact of trade regulations, export
controls and trade disputes. Forward-looking statements speak only as of the date they are made and are subject to risks and
uncertainties that could cause actual results to differ materially from those expressed, including: the severity, magnitude and duration of
the COVID–19 pandemic (and the related governmental, public health, business and community responses to it), and their impacts on our
business, results of operations and financial condition, are evolving and are highly uncertain and unpredictable; business, political and/or
regulatory conditions in the consumer electronics industry, the semiconductor industry and the overall economy may deteriorate or
change; the actions of our customers and competitors may be inconsistent with our expectations; trade regulations, export controls, and
trade disputes may inhibit our ability to sell our products; and widespread outbreaks of illness may impact our operations and revenue in
affected areas; as well as the other factors discussed in our filings with the Securities and Exchange Commission (“SEC”), including
specifically the Risk Factors described in our annual report on Form 10–K for the fiscal year ended June 28, 2020 and our quarterly report
on Form 10-Q for quarter ended September 27, 2020. You should not place undue reliance on forward-looking statements. Lam
undertakes no obligation to update any forward-looking statements.
Cautionary Statement Regarding Forward-Looking Statements

-- 2 of 25 --

Business Review
and Industry
Outlook
TIM ARCHER
PRESIDENT AND CHIEF EXECUTIVE OFFICER

-- 3 of 25 --

© 2021 Lam Research Corp. | 01/27/2021 	4
Global teams rose
to challenges of
COVID-19
Record year:
Revenue of $11.9B
and EPS of $20.45
Strong growth
across systems and
customer support
businesses
Breakthrough
product solutions
provide foundation
for success
2020: 	Strongest Year in Lam History
EPS = earnings per share
Data calculated on a non-GAAP basis. Reconciliations of U.S GAAP results to non-GAAP results can be found at the end of this presentation

-- 4 of 25 --

© 2021 Lam Research Corp. | 01/27/2021 	5
2020 WFE spending estimated in high $50 billion range
2021 WFE spending estimated in high $60s to $70
billion range
Growth in 2020 across all segments of the market led
by a NAND recovery, Foundry/Logic expansion, and a
slight increase in DRAM
Drivers in 2021 include migration to higher layer
counts in NAND, strong spending in DRAM and
Foundry/Logic momentum
WFE = wafer fabrication equipment
Semiconductor Demand and Higher Capital Intensity Support Sustainable
Strength in WFE

-- 5 of 25 --

© 2021 Lam Research Corp. | 01/27/2021 	6
Sense.i™ 	Vantex™
Launched Sense.i™ etch platform,
offering best in class process,
tool footprint and Equipment
Intelligence ® capabilities
Launched first module on
Sense.i™ platform; features
advanced RF technology and
uniformity controls
Striker® FE
Introduced unique ICEFill™
advanced dielectric gapfill for
high aspect-ratio structures
Leveraging Our Widening NAND Leadership to Launch Breakthrough Products

-- 6 of 25 --

© 2021 Lam Research Corp. | 01/27/2021 	7
DRAM
Foundry /
Logic
Growing opportunity in DRAM patterning
in both etch and deposition with EUV
adoption
Unique atomic level etch capabilities and
materials innovation to expand SAM and
Share at key technology inflections
SAM = served available market
Expanding Positions and Delivering Differentiated Technology Beyond NAND

-- 7 of 25 --

© 2021 Lam Research Corp. | 01/27/2021 	8
0
10,000
20,000
30,000
40,000
50,000
60,000
70,000
2015 	2016 	2017 	2018 	2019 	2020
Installed Base Units
Growing Installed Base
Delivering world class support of complex technologies in high volume manufacturing
Calendar year 2020 revenue growth exceeded
chamber count growth by >2x
Record revenues for all sub-segments within
CSBG
▪ 	Reliant growth driven by specialty applications
in auto, 5G, consumer electronics
▪ 	Growth in 2020 calendar year:
− 	25% growth in productivity-focused services
− 	6x growth in remote support engagements
~66,000
~61,000
~56,000
~50,000
~44,000
~40,000
Continued Growth for Customer Support Business Group

-- 8 of 25 --

© 2021 Lam Research Corp. | 01/27/2021 	9
Execution on our strategy to expand
leadership across markets
Record financial performance
Strong slate of innovative new
products and services
Excellent Position to Win

-- 9 of 25 --

December
Quarter 2020
Financial Results
and March
Quarter 2021
Outlook
DOUG BETTINGER
EXECUTIVE VICE PRESIDENT AND CHIEF
FINANCIAL OFFICER

-- 10 of 25 --

© 2021 Lam Research Corp. | 01/27/2021 	11
*Data are presented on a non-GAAP basis. Reconciliations of U.S. GAAP results to non-GAAP results can be found at the end of this presentation
($B)
Total Revenue
Revenue
($B)
Revenue
Earnings per Share*
($)
December Quarter Highlights

-- 11 of 25 --

© 2021 Lam Research Corp. | 01/27/2021 	12
Revenue
Record level of foundry revenue dollars
NVM = non-volatile memory
*Systems revenue includes equipment and equipment upgrade sales from etch, deposition, clean, and our Reliant ® product line
System Revenue Segments*
Logic/Other 	Revenue
Revenue by Region
US Europe
NVM
51%
DRAM
17%
Foundry
26%
6%
China
35%
Korea
21%
Taiwan
17%
Japan
10%
SEA
10%
4% 3%
Memory
68%
December Quarter Revenue Mix

-- 12 of 25 --

© 2021 Lam Research Corp. | 01/27/2021 	13
CSBG Revenue
($B)
Customer Support Business Group

-- 13 of 25 --

© 2021 Lam Research Corp. | 01/27/2021 	14
Q Dec'20 	Q Sep'20
Revenue 	$3,456M 	$3,177M
Non-GAAP Gross Margin* 	46.6% 	47.5%
Non-GAAP Operating Expenses* 	$563M 	$523M
Non-GAAP Operating Income* 	$1,048M 	$988M
Non-GAAP Operating Income as a percentage of Revenue* 	30.3% 	31.1%
Non-GAAP Other Expense, Net* 	$53M 	$51M
U.S. GAAP Diluted EPS 	$5.96 	$5.59
Non-GAAP Diluted EPS* 	$6.03 	$5.67
Diluted Share Count 	146M 	147M
*A reconciliation of U.S. GAAP results to non-GAAP results can be found at the end of this presentation
December Quarter Financial Results

-- 14 of 25 --

© 2021 Lam Research Corp. | 01/27/2021 	15
*Lam’s deferred revenue balance does not include shipments to customers in Japan, to whom title does not transfer until customer acceptance
Estimated future revenue from shipments to customers in Japan was approximately $206M as of December 27, 2020 and $201M as of September 27, 2020
Q Dec'20 	Q Sep'20
Total Consolidated Gross Cash Balance 	$6,295M 	$6,911M
Account Receivables, Net 	$2,900M 	$2,318M
DSO 	76 Days 	66 Days
Inventory Turns 	3.2 	3.1
Deferred Revenue* 	$640M 	$680M
Capital Expenditures 	$92M 	$63M
Equity Compensation Expense 	$52M 	$56M
Amortization Expense 	$17M 	$17M
Depreciation Expense 	$59M 	$56M
Headcount 	~12,200 	~11,700
Key Balance Sheet and Financial Metrics

-- 15 of 25 --

© 2021 Lam Research Corp. | 01/27/2021 	16
A reconciliation of U.S. GAAP projected results to non-GAAP projected results can be found at the end of this presentation
*Based on a diluted share count of approximately 145 million shares
$3.7B 	+/- 	$200M
Revenue
46.0% 	+/- 	1%
Non-GAAP
Gross Margin
30.5% 	+/- 	1%
Non-GAAP
Operating Margin
$6.55 	+/- 	$0.40
Non-GAAP
Earnings per Share*
March 2021 Quarter Guidance

-- 16 of 25 --

Questions
and Answers

-- 17 of 25 --

© 2021 Lam Research Corp. | 01/27/2021 	18
Three Months Ended
December 27,
2020 September 27,
2020
U.S. GAAP net income 	$ 	869,229 	$ 	823,451
Pre-tax non-GAAP items:
Amortization related to intangible assets acquired through certain business combinations - cost of goods sold 	1,270 	1,270
Elective deferred compensation ("EDC") related liability valuation increase - cost of goods sold 	6,089 	3,224
EDC related liability valuation increase - research and development 	10,961 	5,803
Amortization related to intangible assets acquired through certain business combinations - selling, general and
administrative 	12,357 	12,357
EDC related liability valuation increase - selling, general and administrative 	7,307 	3,869
Amortization of note discounts - other expense, net 	1,001 	1,011
Gain on EDC related asset - other expense, net 	(24,207) 	(12,927)
Net income tax benefit on non-GAAP items 	(3,796) 	(2,992)
Non-GAAP net income 	$ 	880,211 	$ 	835,066
Non-GAAP net income per diluted share 	$ 	6.03 	$ 	5.67
U.S. GAAP net income per diluted share 	$ 	5.96 	$ 	5.59
U.S. GAAP and non-GAAP number of shares used for per diluted share calculation 	145,910 	147,248
Reconciliation of U.S. GAAP Net Income to Non-GAAP Net Income
(in thousands, except per share data)
(unaudited)
Appendix – Reconciliation

-- 18 of 25 --

© 2021 Lam Research Corp. | 01/27/2021 	19
Three Months Ended
December 27,
2020 September 27,
2020
U.S. GAAP gross margin 	$ 	1,603,795 	$ 	1,506,179
Pre-tax non-GAAP items:
Amortization related to intangible assets acquired through certain business combinations 	1,270 	1,270
EDC related liability valuation increase 	6,089 	3,224
Non-GAAP gross margin 	$ 	1,611,154 	$ 	1,510,673
U.S. GAAP gross margin as a percentage of revenue 	46.4 	% 	47.4 	%
Non-GAAP gross margin as a percentage of revenue 	46.6 	% 	47.5 	%
U.S. GAAP operating expenses 	$ 	594,071 	$ 	545,115
Pre-tax non-GAAP items:
Amortization related to intangible assets acquired through certain business combinations 	(12,357) 	(12,357)
EDC related liability valuation increase 	(18,268) 	(9,672)
Non-GAAP operating expenses 	$ 	563,446 	$ 	523,086
U.S. GAAP operating income 	$ 	1,009,724 	$ 	961,064
Non-GAAP operating income 	$ 	1,047,708 	$ 	987,587
U.S. GAAP operating income as percent of revenue 	29.2 	% 	30.2 	%
Non-GAAP operating income as a percent of revenue 	30.3 	% 	31.1 	%
Reconciliation of U.S. GAAP Gross Margin, Operating Expenses and Operating Income to Non-GAAP Gross Margin, Operating Expenses and Operating
Income
(in thousands, except percentages)
(unaudited)
Appendix – Reconciliation

-- 19 of 25 --

© 2021 Lam Research Corp. | 01/27/2021 	20
Reconciliation of U.S. GAAP Other Expense, Net to Non-GAAP Other Expense, Net
(in thousands)
(unaudited)
Three Months Ended
December 27,
2020 September 27,
2020
U.S. GAAP Other expense, net 	$ 	(29,941) 	$ 	(38,792)
Pre-tax non-GAAP items:
Amortization of note discounts 	1,001 	1,011
Gain on EDC related asset - other expense, net 	(24,207) 	(12,927)
Non-GAAP Other expense, net 	$ 	(53,147) 	$ 	(50,708)
Appendix – Reconciliation

-- 20 of 25 --

© 2021 Lam Research Corp. | 01/27/2021 	21
Reconciliation of U.S. GAAP Income Tax Rate to Non-GAAP Income Tax Rate
(in thousands, except percentages)
(unaudited)
Three Months Ended
December 27,
2020 September 27,
2020
U.S. GAAP income before income taxes 	$ 	979,783 	$ 	922,272
U.S. GAAP income tax expense 	$ 	110,554 	$ 	98,821
U.S. GAAP income tax rate 	11.3 	% 	10.7 	%
Pre-tax non-GAAP items:
Amortization related to intangible assets acquired through certain business combinations - cost of goods sold 	$ 	1,270 	$ 	1,270
Elective deferred compensation ("EDC") related liability valuation increase - cost of goods sold 	6,089 	3,224
EDC related liability valuation increase - research and development 	10,961 	5,803
Amortization related to intangible assets acquired through certain business combinations - selling, general and
administrative 	12,357 	12,357
EDC related liability valuation increase - selling, general and administrative 	7,307 	3,869
Amortization of note discounts - other expense, net 	1,001 	1,011
Gain on EDC related asset - other expense, net 	(24,207) 	(12,927)
Non-GAAP income before taxes 	$ 	994,561 	$ 	936,879
Net income tax benefit on non-GAAP items 	$ 	3,796 	$ 	2,992
Non-GAAP income tax expense 	$ 	114,350 	$ 	101,813
Non-GAAP income tax rate 	11.5 	% 	10.9 	%
Appendix – Reconciliation

-- 21 of 25 --

© 2021 Lam Research Corp. | 01/27/2021 	22
Reconciliation of U.S. GAAP to Non-GAAP Guidance for the
quarter ended March 28, 2021
The information provided above is only an estimate of what the Company believes is realizable as of the date of this release and does not incorporate the potential
impact of any business combinations, asset acquisitions, divestitures, restructuring, balance sheet valuation adjustments, financing arrangements, other investments,
or other significant arrangements that may be completed after the date of this release. U.S. GAAP to non-GAAP reconciling items provided include only those items
that are known and can be estimated as of the date of this release. Actual results will vary from this model and the variations may be material. Reconciling items
included above are as follows:
 	Gross margin as a percentage of revenue - amortization related to intangible assets acquired through business combinations, $1 million.
 	Operating income as a percentage of revenue - amortization related to intangible assets acquired through business combinations, $13 million.
 	Net income per diluted share - amortization related to intangible assets acquired though business combinations, $13 million; amortization of note discounts,
$1 million; and associated tax benefit for non-GAAP items ($2 million); totaling $12 million.
U.S. GAAP 	Reconciling Items 	Non-GAAP
Revenue 	$3.7 Billion 	+/- 	$200 Million 	— 	$3.7 Billion 	+/- 	$200 Million
Gross margin as a percentage of revenue 	46.0% 	+/- 	1% 	$ 	1 	Million 	46.0% 	+/- 	1%
Operating income as a percentage of revenue 	30.1% 	+/- 	1% 	$ 	13 	Million 	30.5% 	+/- 	1%
Net income per diluted share 	$6.47 	+/- 	$0.40 	$ 	12 	Million 	$6.55 	+/- 	$0.40
Diluted share count 	145 Million 	— 	145 Million
Appendix – Reconciliation

-- 22 of 25 --

© 2021 Lam Research Corp. | 01/27/2021 	23
Reconciliation of U.S. GAAP Net Income to Non-GAAP Net Income
(in thousands, except per share data)
(unaudited)
Twelve Months Ended
December 27,
2020
December 29,
2019
December 29,
2019
(as originally disclosed) (as adjusted for
comparability)
U.S. GAAP net income 	$ 	2,964,134 	$ 	2,069,514 	$ 	2,069,514
Pre-tax non-GAAP items:
Amortization related to intangible assets acquired through certain business combinations - cost of
goods sold 	5,794 	28,986 	28,986
Elective deferred compensation ("EDC") related liability valuation increase - cost of goods sold 	7,040 	— 	10,383
Restructuring charges - cost of goods sold 	— 	3,472 	3,472
Restructuring charges - research and development 	— 	4,904 	4,904
EDC related liability valuation increase - research and development 	12,672 	— 	18,690
Amortization related to intangible assets acquired through certain business combinations - selling,
general and administrative 	49,428 	49,517 	49,517
Restructuring charges - selling, general and administrative 	— 	5,414 	5,414
EDC related liability valuation increase - selling, general and administrative 	8,448 	— 	12,460
Amortization of note discounts - other expense, net 	3,900 	4,543 	4,543
Gain on EDC related asset - other expense, net 	(29,441) 	— 	(41,318)
Net income tax benefit on non-GAAP items 	(10,786) 	(14,678) 	(16,541)
Income tax benefit on the conclusion of certain tax matters 	(276) 	(3,094) 	(3,094)
Cumulative income tax benefit reversal due to a court ruling 	(821) 	74,516 	74,516
Income tax expense associated with U.S. tax reform 	— 	1,453 	1,453
Non-GAAP net income 	$ 	3,010,092 	$ 	2,224,547 	$ 	2,222,899
Non-GAAP net income per diluted share 	$ 	20.45 	$ 	14.51 	$ 	14.49
U.S. GAAP net income per diluted share 	$ 	20.14 	$ 	13.49 	$ 	13.49
U.S. GAAP and non-GAAP number of shares used for per diluted share calculation 	147,185 	153,362 	153,362
Appendix – Reconciliation

-- 23 of 25 --

© 2021 Lam Research Corp. | 01/27/2021 	24
Calculation of Free Cash Flows
(in thousands)
(unaudited)
U.S. GAAP net cash provided by operating activities for the quarter ended:
March 29, 2020 	$541,428
June 28, 2020 	813,048
September 27, 2020 	642,511
December 27, 2020 	344,637
U.S. GAAP cash used for capital expenditures and intangible assets for the quarter ended:
March 29, 2020 	(51,375)
June 28, 2020 	(50,554)
September 27, 2020 	(62,806)
December 27, 2020 	(92,072)
Total free cash flows for calendar year ending December 27, 2020 	$2,084,817
Appendix – Reconciliation

-- 24 of 25 --



-- 25 of 25 --